Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis
Trial details
- Registry ID
- NCT02004041
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic DermatitisNCT02004041 | Vanda Pharmaceuticals | Phase 2 | Completed | 2015-02-19Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |